CYCC Bio Green Med Solution Inc.


$ 1.34 $ 0.00 (0 %)    

Friday, 14-Nov-2025 13:12:14 EST
QQQ $ 611.62 $ 12.06 (2.01 %)
DIA $ 473.32 $ 1.87 (0.4 %)
SPY $ 674.34 $ 8.88 (1.33 %)
TLT $ 88.97 $ -0.82 (-0.91 %)
GLD $ 376.74 $ 3.85 (1.03 %)
$ 1.34
$ 1.34
$ 1.33 x 1
$ 1.34 x 231
$ 1.34 - $ 1.34
$ 1.26 - $ 101.30
77,969
na
na
$ 1.30
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION